EA202192541A1 - Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин - Google Patents

Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин

Info

Publication number
EA202192541A1
EA202192541A1 EA202192541A EA202192541A EA202192541A1 EA 202192541 A1 EA202192541 A1 EA 202192541A1 EA 202192541 A EA202192541 A EA 202192541A EA 202192541 A EA202192541 A EA 202192541A EA 202192541 A1 EA202192541 A1 EA 202192541A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
amitriptiline
local application
water gel
water
Prior art date
Application number
EA202192541A
Other languages
English (en)
Inventor
Паола Принсипе Николас
Фредерик Лаллеман
Стефан Тиролуа
Original Assignee
Альготерапьютикс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альготерапьютикс filed Critical Альготерапьютикс
Publication of EA202192541A1 publication Critical patent/EA202192541A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к топической фармацевтической композиции в виде водного геля, включающей, по меньшей мере, амитриптилин и/или одну из его фармацевтически приемлемых солей, в содержании от 10 до 30 вес.% от полного веса композиции, и воду.
EA202192541A 2020-04-06 2021-03-31 Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин EA202192541A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2003425A FR3108841B1 (fr) 2020-04-06 2020-04-06 Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
PCT/EP2021/058518 WO2021204634A1 (fr) 2020-04-06 2021-03-31 Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l'amitriptyline

Publications (1)

Publication Number Publication Date
EA202192541A1 true EA202192541A1 (ru) 2021-11-26

Family

ID=71894918

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192541A EA202192541A1 (ru) 2020-04-06 2021-03-31 Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин

Country Status (14)

Country Link
US (3) US20220304949A1 (ru)
EP (1) EP4106726B1 (ru)
JP (1) JP7295273B2 (ru)
KR (1) KR20210153085A (ru)
CN (1) CN113966212A (ru)
AU (1) AU2021229214B2 (ru)
BR (1) BR112021022564A2 (ru)
CA (1) CA3130171C (ru)
EA (1) EA202192541A1 (ru)
ES (1) ES3045060T3 (ru)
FR (1) FR3108841B1 (ru)
IL (1) IL286390A (ru)
MX (1) MX2021011572A (ru)
WO (1) WO2021204634A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
CN120585733A (zh) * 2025-06-18 2025-09-05 兰州大学第一医院 一种阿米替林凝胶及其制备方法和应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131576A (en) 1977-12-15 1978-12-26 National Starch And Chemical Corporation Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
CA2335837A1 (en) * 1998-06-29 2000-01-06 Pharmaceuticals Applications Associates, Llc Methods and transdermal compositions for pain relief
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
CA2315815A1 (en) * 2000-07-19 2002-01-19 Peter R. Ford Topical pain relief composition and carrier
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
WO2003035080A2 (en) * 2001-08-28 2003-05-01 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
WO2003055475A1 (en) 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
US7687080B2 (en) 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20050209220A1 (en) 2004-03-19 2005-09-22 Jeffrey Conforti Treatment of peripheral neuropathy
CN101494976B (zh) 2005-12-14 2013-12-18 努沃研究公司 用于经皮肤治疗痛的组合物和方法
US20080095831A1 (en) 2006-08-10 2008-04-24 Mc Graw Thomas L Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
US8394759B2 (en) 2008-11-21 2013-03-12 Cymbiotics, Inc. Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes
EP2419138A4 (en) * 2009-04-14 2013-08-21 Medortus Uk Ltd GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
JP2013508381A (ja) * 2009-10-21 2013-03-07 オトノミ―，インク． ポロクサマーを包含する製剤のゲル化温度の調節
GB0921686D0 (en) 2009-12-11 2010-01-27 Reckitt Benckiser Healthcare I Topical formulation
AU2012289968B2 (en) 2011-08-04 2014-01-16 Omeros Corporation Stable anti-inflammatory solutions for injection
EP3145548B1 (en) 2014-05-22 2022-04-13 University of Copenhagen Aqueous gel composition and its use
US20160101166A1 (en) * 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
JP6856620B2 (ja) * 2015-07-27 2021-04-07 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 薬剤搭載ナノ樹脂粒子
CA3045004A1 (en) 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
US11299557B2 (en) 2016-04-04 2022-04-12 Shin-Etsu Chemical Co., Ltd. Method for producing water-soluble nonionic cellulose ether powder having high bulk density
FI3551166T3 (fi) 2016-12-06 2024-10-04 Topical Innovations B V Topikaalinen fenytoiini perifeerisen neuropaattisen kivun hoitoon
EP3551182B1 (en) 2016-12-06 2025-03-19 Topical Innovations B.V. Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
FR3065371B1 (fr) * 2017-04-25 2021-05-21 Laboratoires Mayoly Spindler Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques
US12005034B2 (en) 2017-04-25 2024-06-11 Algotherapeutix Topical pharmaceutical composition comprising at least amitriptyline, for the treatment of peripheral neuropathic pain
KR20220003519A (ko) 2019-03-26 2022-01-10 윈산토르, 아이엔씨. 말초 신경병증 치료를 위한 국소 제형
CN110338191B (zh) 2019-06-06 2020-10-20 中国农业大学 阿米替林在植物疫病防治中作为杀菌增效剂的应用
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
FR3120787B1 (fr) 2021-03-19 2024-04-26 Algotherapeutix Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline
FR3123563B1 (fr) 2021-06-03 2025-02-14 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
FR3127689B1 (fr) 2021-10-01 2024-10-04 Algotherapeutix Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques du membre fantôme
FR3127688B1 (fr) 2021-10-01 2024-10-04 Algotherapeutix Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques induites par un coronavirus

Also Published As

Publication number Publication date
EP4106726A1 (fr) 2022-12-28
CN113966212A (zh) 2022-01-21
US12156854B2 (en) 2024-12-03
AU2021229214A1 (en) 2021-10-21
US12150920B2 (en) 2024-11-26
BR112021022564A2 (pt) 2022-10-11
EP4106726C0 (fr) 2025-09-03
EP4106726B1 (fr) 2025-09-03
CA3130171A1 (fr) 2021-10-06
IL286390A (en) 2021-12-01
US20240293341A1 (en) 2024-09-05
FR3108841A1 (fr) 2021-10-08
WO2021204634A1 (fr) 2021-10-14
JP7295273B2 (ja) 2023-06-20
US20240277630A1 (en) 2024-08-22
CA3130171C (fr) 2024-05-21
KR20210153085A (ko) 2021-12-16
US20220304949A1 (en) 2022-09-29
ES3045060T3 (en) 2025-11-27
MX2021011572A (es) 2022-01-24
JP2022531708A (ja) 2022-07-08
FR3108841B1 (fr) 2023-11-03
AU2021229214B2 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
JOP20230138A1 (ar) مثبطات prmt5
YU14495A (sh) Jedinjenja koja su prolekovi antagonista morfolin tahikininskih receptora i njihove farmaceutske kompozicije
BR112022024943A2 (pt) Composição oral efervescente compreendendo um ingrediente ativo
FI3810201T3 (fi) GIP/GLP1-agonistin koostumuksia
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
PH12022550338A1 (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
BR0107811A (pt) Composição herbicida
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
MX383804B (es) Derivados de piperidina.
FI3817751T3 (fi) Vedettömän natriumtiosulfaatin formulaatioita
MX373040B (es) Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservador.
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
MX2023005039A (es) Derivados de 2-hidroxicicloalcan-1-carbamoilo que inhiben la galectina-3.
MX382264B (es) Composiciones que comprenden amlodipina y bisoprolol.
BR9908301A (pt) Derivados de indol e composições farmacêuticas que compreendem os mesmos
PE20250835A1 (es) Composiciones y uso de la tirzepatida
PH12020551342A1 (en) Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof
EA201892563A1 (ru) Композиция для местного применения
UA87841C2 (ru) Композиция, которая содержит амброксол, для местного применения
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
MX2021011572A (es) Composicion farmaceutica topica en forma de gel acuoso que contiene por lo menos amitriptilina.
PT1414467E (pt) Tratamento topico da mastalgia
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral